136 related articles for article (PubMed ID: 38057686)
21. Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients.
Lin PH; Chen SC; Tseng LM; Chang KJ; Huang AC; Cheng KC; Yang K; Wu HC; Chao TY; Chang YC; Lin PC; Kuo WH; Kuo WL; Lin CH; Chen HM; Yeh DC; Liu LC; Liu CY; Wang MY; Lo C; Lu YS; Huang CS
Breast Cancer Res Treat; 2022 Apr; 192(3):629-637. PubMed ID: 35113257
[TBL] [Abstract][Full Text] [Related]
22. Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
Danzinger S; Tan YY; Rudas M; Kastner MT; Weingartshofer S; Muhr D; Singer CF
BMC Cancer; 2019 Jul; 19(1):695. PubMed ID: 31307407
[TBL] [Abstract][Full Text] [Related]
23. Treatment of women with BRCA mutation.
Depypere H
Climacteric; 2023 Jun; 26(3):235-239. PubMed ID: 37011662
[TBL] [Abstract][Full Text] [Related]
24. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling.
Melki R; Melloul M; Aissaoui S; El Harroudi T; Boukhatem N
BMC Cancer; 2023 Apr; 23(1):339. PubMed ID: 37055759
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
27. HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
van der Groep P; van Diest PJ; Smolders YH; Ausems MG; van der Luijt RB; Menko FH; Bart J; de Vries EG; van der Wall E
PLoS One; 2013; 8(2):e56055. PubMed ID: 23409121
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known
Çalım-Gürbüz B; Güvendir İ; Ünal B; Erdoğan-Durmuş Ş; Topal CS; Ağaoğlu NB; Doğanay HL; Kızılboğa T; Zemheri IE
Int J Surg Pathol; 2022 Jun; 30(4):397-404. PubMed ID: 35261270
[No Abstract] [Full Text] [Related]
29. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients.
Rogozińska-Szczepka J; Utracka-Hutka B; Grzybowska E; Maka B; Nowicka E; Smok-Ragankiewicz A; Zientek H; Steffen J; Wojciechowska-Łacka A
Ann Oncol; 2004 Sep; 15(9):1373-6. PubMed ID: 15319244
[TBL] [Abstract][Full Text] [Related]
31. Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi A; Ghourabi ME; Fourati A; Chaabouni-Bouhamed H
Breast Cancer; 2017 Mar; 24(2):238-244. PubMed ID: 27025497
[TBL] [Abstract][Full Text] [Related]
32. Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
Eerola H; Heinonen M; Heikkilä P; Kilpivaara O; Tamminen A; Aittomäki K; Blomqvist C; Ristimäki A; Nevanlinna H
Breast Cancer Res; 2008; 10(1):R17. PubMed ID: 18275599
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
Ryu JM; Choi HJ; Kim I; Nam SJ; Kim SW; Yu J; Lee SK; Choi DH; Park YH; Kim JW; Seo JS; Park JH; Lee JE; Kim SW;
Breast Cancer Res Treat; 2019 Jan; 173(2):385-395. PubMed ID: 30350268
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Proteomic Profiling-derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas.
Vos S; Elias SG; van der Groep P; Smolders YH; van Gils CH; van Diest PJ
Am J Surg Pathol; 2018 Sep; 42(9):1262-1272. PubMed ID: 29979200
[TBL] [Abstract][Full Text] [Related]
35. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.
Mullooly M; Yang HP; Falk RT; Nyante SJ; Cora R; Pfeiffer RM; Radisky DC; Visscher DW; Hartmann LC; Carter JM; Degnim AC; Stanczyk FZ; Figueroa JD; Garcia-Closas M; Lissowska J; Troester MA; Hewitt SM; Brinton LA; Sherman ME; Gierach GL
Breast Cancer Res; 2017 Jan; 19(1):8. PubMed ID: 28103902
[TBL] [Abstract][Full Text] [Related]
36. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers.
Ikejima K; Tokioka S; Yagishita K; Kajiura Y; Kanomata N; Yamauchi H; Kurihara Y; Tsunoda H
J Med Ultrason (2001); 2023 Apr; 50(2):213-220. PubMed ID: 36905492
[TBL] [Abstract][Full Text] [Related]
38. Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.
Grill S; Yahiaoui-Doktor M; Dukatz R; Lammert J; Ullrich M; Engel C; Pfeifer K; Basrai M; Siniatchkin M; Schmidt T; Weisser B; Rhiem K; Ditsch N; Schmutzler R; Bischoff SC; Halle M; Kiechle M
Arch Gynecol Obstet; 2017 Dec; 296(6):1135-1144. PubMed ID: 28975393
[TBL] [Abstract][Full Text] [Related]
39. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
40. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
